Thyrocare Technologies Limited has announced the successful completion of its Non-Convertible Debentures (NCDs) redemption and the subsequent release of the pledge over its equity shares. This action, effective August 19, 2026, signifies the full discharge of obligations under the relevant transaction documents, marking a significant financial milestone for the company.
Thyrocare Technologies Concludes NCD Redemption
Thyrocare Technologies Limited has officially announced the complete redemption and repayment of its Non-Convertible Debentures (NCDs) by API Holdings Limited. This development, effective August 19, 2026, has resulted in the full discharge of all related transaction documents and the complete release of the pledge over the equity shares of the Company.
Key Transaction Details
The original execution date of the transaction documents was September 11, 2025. The NCDs, aggregating to INR 1,700 crore, were secured by pledge of equity shares. Following the full redemption and repayment, there is no impact on the Company, as the pledge over the equity shares has been fully released and all obligations under the transaction documents have been discharged.
Source: BSE
